Idiopathic pulmonary arterial hypertension — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Escalation to parenteral prostacyclin-based combination therapy
High-risk PAH with syncope, low cardiac index and high PVR requires specialist escalation, often including parenteral prostacyclin therapy. Diuretics help congestion but do not treat the pulmonary arteriopathy. Risk stratification drives PAH therapy rather than symptoms alone.
Reference: ESC/ERS Pulmonary Hypertension Guideline 2022